| Name | Title | Contact Details |
|---|---|---|
Ryan Dagon |
Senior Director, Marketing Technology and | Profile |
Ken Fairleigh |
Vice President, Operations and Supply Chain | Profile |
Brenda Everson |
Senior Vice President of Human Resources | Profile |
Jennifer Scott |
Director, HR Diagnostics and Genomics | Profile |
Struan Robertson |
Vice President of Human Resources | Profile |
Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. Carisma Therapeutics is headquartered in Philadelphia, PA.
Cleave Biosciences is a biopharmaceutical company pioneering the development of novel protein homeostasis inhibitors for the treatment of cancer.
Oncoceutics Pharmaceuticals Inc is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Hess Associates is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Axovant Sciences is a leading clinical-stage neurology company focused on the treatment of dementia and related neurological disorders. We aspire to lead the way into a new era of progress to protect the fullness of life for people living with neurologic conditions. We see the potential of compelling therapeutic pathways and set our sights high on creating life-changing advancement for millions of people affected by neurologic disorders.